GSK3B and posterior cortical atrophy: The results showed that PCMT1 inhibition decreased the levels of P-AKT and P-GSK-3β (Figure 5C), suggesting that PCMT1 may regulate PCa progression by modulating the PI3K/AKT/GSK-3β signaling pathway.